Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingvild Birschmann

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 7, 2010
ADAMTS13--marker of contractile phenotype of arterial smooth muscle cells lost in benign nephrosclerosisClemens L Bockmeyer, Vinzent Forstmeier, Friedrich Modde, et al.
European Heart Journal|May 13, 2017
Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D dailyArmin Zittermann, Jana B Ernst, Sylvana Prokop, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 10, 2012
Arteriolar vascular smooth muscle cell differentiation in benign nephrosclerosisClemens Luitpold Bockmeyer, David Sebastian Kern, Vinzent Forstmeier, et al.
Deutsches Arzteblatt International|July 2, 2020
Severe Hemorrhage Associated With Oral AnticoagulantsEdelgard Lindhoff-Last, Eva Herrmann, Simone Lindau, et al.
Journal of Clinical Medicine|January 11, 2024
Clinical Course and Management of Patients with Emergency Surgery Treated with Direct Oral Anticoagulants or Vitamin K Antagonists-Results of the German Prospective RADOA-RegistryJana Last, Eva Herrmann, Ingvild Birschmann, et al.
Thrombosis and Haemostasis|July 13, 2021
Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-RegistryEdelgard Lindhoff-Last, Ingvild Birschmann, Joachim Kuhn, et al.
Hamostaseologie|January 27, 2025
The Diagnostic Assessment of Inherited Platelet Function Defects - Part 1: An Overview of the Diagnostic Approach and Laboratory MethodsGero Hoepner, Karina Althaus, Jens Müller, et al.
Hamostaseologie|January 27, 2025
The Diagnostic Assessment of Platelet Function Defects - Part 2: Update on Platelet DisordersKarina Althaus, Gero Hoepner, Barbara Zieger, et al.
Pharmaceuticals (Basel, Switzerland)|November 24, 2022
Pharmacokinetics of Phenprocoumon in Emergency Situations-Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry)Edelgard Lindhoff-Last, Ingvild Birschmann, Antonia J Bidenharn, et al.
Blood|June 20, 2013
Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trialPier Mannuccio Mannucci, Christine Kempton, Carolyn Millar, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 7, 2010
ADAMTS13--marker of contractile phenotype of arterial smooth muscle cells lost in benign nephrosclerosisClemens L Bockmeyer, Vinzent Forstmeier, Friedrich Modde, et al.
European Heart Journal|May 13, 2017
Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D dailyArmin Zittermann, Jana B Ernst, Sylvana Prokop, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 10, 2012
Arteriolar vascular smooth muscle cell differentiation in benign nephrosclerosisClemens Luitpold Bockmeyer, David Sebastian Kern, Vinzent Forstmeier, et al.
Deutsches Arzteblatt International|July 2, 2020
Severe Hemorrhage Associated With Oral AnticoagulantsEdelgard Lindhoff-Last, Eva Herrmann, Simone Lindau, et al.
Journal of Clinical Medicine|January 11, 2024
Clinical Course and Management of Patients with Emergency Surgery Treated with Direct Oral Anticoagulants or Vitamin K Antagonists-Results of the German Prospective RADOA-RegistryJana Last, Eva Herrmann, Ingvild Birschmann, et al.
Thrombosis and Haemostasis|July 13, 2021
Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-RegistryEdelgard Lindhoff-Last, Ingvild Birschmann, Joachim Kuhn, et al.
Hamostaseologie|January 27, 2025
The Diagnostic Assessment of Inherited Platelet Function Defects - Part 1: An Overview of the Diagnostic Approach and Laboratory MethodsGero Hoepner, Karina Althaus, Jens Müller, et al.
Hamostaseologie|January 27, 2025
The Diagnostic Assessment of Platelet Function Defects - Part 2: Update on Platelet DisordersKarina Althaus, Gero Hoepner, Barbara Zieger, et al.
Pharmaceuticals (Basel, Switzerland)|November 24, 2022
Pharmacokinetics of Phenprocoumon in Emergency Situations-Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry)Edelgard Lindhoff-Last, Ingvild Birschmann, Antonia J Bidenharn, et al.
Blood|June 20, 2013
Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trialPier Mannuccio Mannucci, Christine Kempton, Carolyn Millar, et al.
Pageof 7